Real-time enrollment status for this head and neck cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:19 AM UTC
| NCT Number | NCT06295731 |
| Recruiting Status | Recruiting |
| Condition | Head and Neck Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 410 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Inhibrx Biosciences, Inc |
| Last Updated on CT.gov | November 17, 2025 (Nov 17, 2025) |
As of March 2, 2026: Clinical trial NCT06295731 is currently recruiting participants. This clinical trial study for head and neck cancer is actively seeking new participants at 25 locations across the United States. The study is sponsored by Inhibrx Biosciences, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06295731 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06295731 was last updated Nov 17, 2025 (November 17, 2025). HelloStudys verifies this status automatically.